Evidence map›Paper›PMID 12639997›Full record

ArticleThe Journal of clinical investigation2003

Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.

Vanda A Lennon, Leonid G Ermilov, Joseph H Szurszewski, Steven Vernino

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 176 citations in OpenAlex.

  1. Review
  2. Autonomic dysfunction and its association with sexual dysfunction in myasthenia gravis.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Article
  3. Review
  4. Article
  5. A case of seropositive autoimmune autonomic ganglionopathy treated with rituximab: Case report and review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  6. Autoimmune autonomic ganglionopathy and myasthenia gravis: a case report and review of the literature.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Article
  7. Article
  8. Autoimmune Autonomic Neuropathy: From Pathogenesis to Diagnosis.International journal of molecular sciences · 2024
    Review
  9. Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Nausea and Vomiting in 2021: A Comprehensive Update.Journal of clinical gastroenterology · 2021
    Review
  15. Article
  16. Gastrointestinal motility disorders in neurologic disease.The Journal of clinical investigation · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Vanda A LennonDepartment of Immunology, Mayo Graduate and Medical Schools and Mayo Clinic, Rochester, Minnesota 55905, USA. lennon.vanda@mayo.edu
Leonid G Ermilov
Joseph H Szurszewski
Steven Vernino
Mayo Clinic · USMayo Clinic in Florida · USWinnMed · US

Funding

EXPERIMENTAL AUTOIMMUNE AUTONOMIC NEUROPATHYK08NS002247 · NINDS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI VERNINO, STEVEN A · 2001 to 2005
$654k
PARANEOPLASTIC AUTOIMMUNITY--CALCIUM CHANNELSR01CA037343 · NCI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI LENNON, VANDA A · 1985 to 1996
–
NCI NIH HHS CA37343NIDDK NIH HHS DK17636NINDS NIH HHS K08 NS002247NINDS NIH HHS NS02247
6 · The paper itself

Abstract

Neuronal nicotinic AChRs (nAChRs) are implicated in the pathogenesis of diverse neurological disorders and in the regulation of small-cell lung carcinoma growth. Twelve subunits have been identified in vertebrates, and mutations of one are recognized in a rare form of human epilepsy. Mice with genetically manipulated neuronal nAChR subunits exhibit behavioral or autonomic phenotypes. Here, we report the first model of an acquired neuronal nAChR disorder and evidence for its pertinence to paraneoplastic neurological autoimmunity. Rabbits immunized once with recombinant alpha3 subunit (residues 1-205) develop profound gastrointestinal hypomotility, dilated pupils with impaired light response, and grossly distended bladders. As in patients with idiopathic and paraneoplastic autoimmune autonomic neuropathy, the severity parallels serum levels of ganglionic nAChR autoantibody. Failure of neurotransmission through abdominal sympathetic ganglia, with retention of neuronal viability, confirms that the disorder is a postsynaptic channelopathy. In addition, we found ganglionic nAChR protein in small-cell carcinoma lines, identifying this cancer as a potential initiator of ganglionic nAChR autoimmunity. The data support our hypothesis that immune responses driven by distinct neuronal nAChR subtypes expressed in small-cell carcinomas account for several lung cancer-related paraneoplastic disorders affecting cholinergic systems, including autoimmune autonomic neuropathy, seizures, dementia, and movement disorders.

Indexed as

AnimalsAutoantibodiesAutoimmune Diseases of the Nervous SystemAutonomic Nervous System DiseasesCarcinoma, Small CellEye DiseasesFemaleGanglia, AutonomicHumansImmunizationLung NeoplasmsRabbitsReceptors, NicotinicTumor Cells, CulturedUrinary Bladder DiseasesAutoantibodiesReceptors, Nicotinic

Identifiers

PMID12639997
PMCPMC153771
OpenAlexW2108349925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.